ArticleMedicina (Kaunas, Lithuania)2024

Reduced-Dose or Discontinuation of Bevacizumab Might Be Considered after Variceal Bleeding in Patients with Hepatocellular Carcinoma Receiving Atezolizumab/Bevacizumab: Case Reports.

Kyeong-Min Yeom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.